AstraZeneca PLC third quarter and nine months financial results 2009
AstraZeneca delivers strong third quarter performance
Increases full-year guidance
<> <>
AstraZeneca announces
· Third quarter revenue increased by 10% at constant exchange rates (CER) ...
This content is available to DeHavilland subscribers only
For more information on our services or to request a limited FREE TRIAL, please visit our website
Please note: This is not an instant access service; DeHavilland services are tailored to the specific needs of each client.
For any other queries please send us an email
DeHavilland - the leading UK parliamentary monitoring and political research service.
DeHavilland provides a wide range of political news and information centred on the UK and European agenda.
Our information keeps leading organisations informed of the latest parliamentary developments which have a direct impact on their public affairs, government relations and communications objectives.
Visit our website for more information
